InvestorsHub Logo
Followers 6
Posts 1142
Boards Moderated 0
Alias Born 02/13/2010

Re: None

Tuesday, 12/17/2013 5:16:25 PM

Tuesday, December 17, 2013 5:16:25 PM

Post# of 9289
The real surge in pps will be when the FDA approves Lymphoseek for the sNDA terms within 6 months. Profits and revenues could easily be 10X higher than they have been thus far.

Moreover, if European Approval for the expanded label happens, we should see 2.50 because if the EU approves Lymphoseek with the expanded label, it is an excellent bet that the FDA will do the same within 6 months in response to today's sNDA.

The turnaround is real...

GLTA.